American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving
Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary.
Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data
The new-look mitral valve is built using LifePolymer, a proprietary material that does not include any animal tissue. Both the frame and its leaflets are robotically generated to match each patient’s anatomy.
How anti-DEI healthcare policies are impacting patient care
All over the United States, countless research projects designed to improve outcomes have lost funding or been shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.
TTVR with Evoque system linked to positive real-world outcomes after 30 days
According to early real-world data, the FDA-approved Evoque TTVR device is associated with positive outcomes when used to treat severe tricuspid regurgitation.
A closer look at world’s first TAVR patient treated with new cerebral embolic protection device
The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.

Cardiologist William C. Roberts remembered as a ‘true legend in cardiovascular medicine’

Roberts was a passionate cardiac pathologist known for his focus and determination. “To say Bill Roberts will be missed is a massive understatement,” one colleague said.

How cath labs can limit waste and become more sustainable

Making cardiac catheterization labs more efficient and less wasteful could help reduce the large carbon footprint associated with healthcare, according to a new commentary published in JACC: Cardiovascular Interventions.

New U.S. guidelines on chronic coronary disease rethink use of beta-blockers, other medications

The updated recommendations from the American College of Cardiology and American Heart Association cover a variety of topics, including patient communication, follow-up imaging, nutritional supplements and more.

Permanent pacemakers after TAVR: Tracking the impact of modern self-expanding valves

Researchers explored data from more than 3,000 TAVR patients, presenting their results in JACC: Cardiovascular Interventions.

Cathleen Dalton Biga, MSN, RN, and Christopher Kramer, MD

American College of Cardiology chooses next president, vice president

ACC Vice President Cathleen Dalton Biga, MSN, RN, will serve as the group's next president. Cardiologist Christopher Kramer, MD, will be its next vice president.

Interventional cardiologists, electrophysiologists ask CMS to clarify policy after unexpected denials

Three cardiology societies have reached out to CMS with questions about how MACs are interpreting a policy related to shared decision-making.

Cardiology societies say affirmative action ruling will do long-term damage to patient care

The American College of Cardiology, Association of Black Cardiologists and several other U.S. societies released a new joint statement on the ruling.

Video of Jon Lindner explaining the use of ultrasound and bubble contrast for therapy.

Cardiac ultrasound could lead to key advances in heart attack care, drug delivery

Jonathan Lindner, MD, offers an update on the use of echocardiography and bubble contrast agents in a therapy role to help revascularize STEMI patients and increase drug and gene delivery.

American College of Cardiology (ACC)

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving

Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data

How anti-DEI healthcare policies are impacting patient care

TTVR with Evoque system linked to positive real-world outcomes after 30 days

A closer look at world’s first TAVR patient treated with new cerebral embolic protection device